Commentary: Iloprost for cholesterol emboli syndromeBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7337.609 (Published 09 March 2002) Cite this as: BMJ 2002;324:609
- Charles D Pusey, professor of renal medicine
- Faculty of Medicine, Imperial College, Hammersmith Hospital, London W12 0NN
In a recent research pointer Elinav et al describe four cases of cholesterol emboli syndrome treated with iloprost.1 Their main observations were improvement in distal extremity ischaemia in all cases and improvement in renal function in the one patient with acute renal impairment.
Cholesterol emboli syndrome …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial